Correlation Between GlaxoSmithKline PLC and EXPEDIA
Specify exactly 2 symbols:
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and EXPEDIA INC, you can compare the effects of market volatilities on GlaxoSmithKline PLC and EXPEDIA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of EXPEDIA. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and EXPEDIA.
Diversification Opportunities for GlaxoSmithKline PLC and EXPEDIA
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between GlaxoSmithKline and EXPEDIA is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and EXPEDIA INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EXPEDIA INC and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with EXPEDIA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EXPEDIA INC has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and EXPEDIA go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and EXPEDIA
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 2.44 times more return on investment than EXPEDIA. However, GlaxoSmithKline PLC is 2.44 times more volatile than EXPEDIA INC. It trades about 0.02 of its potential returns per unit of risk. EXPEDIA INC is currently generating about 0.03 per unit of risk. If you would invest 3,273 in GlaxoSmithKline PLC ADR on August 31, 2024 and sell it today you would earn a total of 140.00 from holding GlaxoSmithKline PLC ADR or generate 4.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 98.93% |
Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. EXPEDIA INC
Performance |
Timeline |
GlaxoSmithKline PLC ADR |
EXPEDIA INC |
GlaxoSmithKline PLC and EXPEDIA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GlaxoSmithKline PLC and EXPEDIA
The main advantage of trading using opposite GlaxoSmithKline PLC and EXPEDIA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, EXPEDIA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXPEDIA will offset losses from the drop in EXPEDIA's long position.GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
EXPEDIA vs. Trupanion | EXPEDIA vs. Sun Life Financial | EXPEDIA vs. Maiden Holdings | EXPEDIA vs. SunLink Health Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Money Managers Screen money managers from public funds and ETFs managed around the world |